Skip to: Content
Skip to: Site Navigation
Skip to: Search

August 30, 2008 10:07:10 CDT



Vaccines, Medicines to Treat Addiction on the Way

Posted Feb 25, 08 1:45 PM CST in Science & Health 

(Newser) – It's been decades since scientists recognized that addiction is a disease, not just a lack of willpower, but only now are potential treatments coming online that address what Newsweek calls "a chronic, relapsing brain disorder to be managed with all the tools at medicine's disposal." The magazine surveys recent breakthroughs, from pills that prevent intoxication to vaccines that turn antibodies against addictive agents.

Some compounds have the ability to intervene in the cortex just as the impulse to drink translates into action, suggesting, as Newsweek puts it, that "willpower-in-a-pill may be just over the horizon." Such drugs may raise ethical and legal issues. "Lawyers certainly want to argue with us on the ethics of it," said a doctor who developed a vaccine for cocaine, "but parent groups and pediatricians have been receptive to the idea."

Source Newsweek

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
This image shows the cover of the March 3 issue of Newsweek (on sale today). The cover story, summarized here, deals with the search for medicines that can treat addiction.   (Associated Press)
  (Shutterstock)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 1)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »